BACKGROUND: Exercise training is an important component of pulmonary rehabilitation, but it remains questionable how training intensity affects patient-centered outcomes. The aim of this study was to compare the effects of 2 aerobic training intensities on health-related quality of life (HRQOL), symptom control, and exercise tolerance in subjects with COPD. METHODS: Thirtyfour subjects with mild to very severe COPD participated in an equivalence/non-inferiority randomized controlled trial with a parallel group blinded to 60 or 80% maximum work rate (W max ) aerobic training intensity. The intervention was an out-patient pulmonary rehabilitation program conducted 3 times/week for 8 weeks. Outcomes were assessed with the St George Respiratory Questionnaire (primary outcome), Mahler's dyspnea index, London Chest Activity of Daily Living scale, 6-min walk test, and constant-load and incremental exercise tests. RESULTS: Subjects were randomly allocated to aerobic training intensity of 60% W max (group 1, n ‫؍‬ 17) or 80% W max (group 2, n ‫؍‬ 17). Although there were significant improvements in all outcomes for both groups, there were no between-group differences in mean change in the St George Respiratory Questionnaire (P ‫؍‬ .31, 95% CI ؊12.0 to 3.9), Mahler's dyspnea index (P ‫؍‬ .38), London Chest Activity of Daily Living scale (P ‫؍‬ .92), 6-min walk test (P ‫؍‬ .50, 95% CI 6.2-71.1), constant-load exercise test (P ‫؍‬ .50), and incremental exercise test (P ‫؍‬ .12). There was only one exercise-related adverse event of cardiac symptoms. CONCLUSIONS: Aerobic training intensity of at least 60% W max has a positive impact on COPD patient-centered outcomes, with no additional benefit of increasing intensity to 80% W 
Introduction
COPD is the world's fourth leading cause of mortality 1 and is projected in 2020 to be the fifth leading disease in morbidity impact. 2 Exercise intolerance in these patients is multifactorial and explained by several known mechanisms. [3] [4] [5] The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends, with level A evidence, pulmonary rehabilitation programs to all symptom-atic patients with COPD. 6 Although this exercise-based treatment is scientifically established in published guidelines, [7] [8] [9] [10] [11] [12] there is a wide range of studies presenting diverse exercise-training methodologies in clinical practice. 13, 14 Aerobic exercise training is recommended 3-5 times/week for at least 20 sessions of 30 -90 min at 60 -80% maximum work rate (W max ) of continuous or intermittent use of a treadmill, bicycle, step, elliptic, or rowing machine. 7, 15, 16 Current investigation has not yet identified the critical exercise intensity, 17 but it is established that physiological benefits are achieved with a minimum of 60% W max and that the higher the intensities, the greater the physiological benefits. 10, 13, 18 Furthermore, it has not been proven conclusively that these physiological benefits would lead to greater improvements in patientcentered outcomes. 7, 15, 16 Current patient-centered outcomes provide the strongest evidence of the impact of pulmonary rehabilitation programs on patients with COPD 19 by measuring improvement in symptoms, exercise performance, and quality of life, which are the most meaningful changes for the patient. Considering the intensity range recommended by international guidelines of 60 -80% W max , we do not know whether higher intensities achieve the best impact on patient-centered outcomes. For this purpose, we tested the hypothesis that 2 aerobic training intensities (60 and 80% W max ) had equal or non-inferior effects on COPD patient-centered outcomes: healthrelated quality of life (HRQOL), symptom control, and exercise tolerance.
Methods
This was an equivalence/non-inferiority trial with blocked stratified randomization of subject-blinded assignment in a parallel group design, with an allocation ratio of 1:1. Eligible participants were stable subjects with COPD, with FEV 1 /FVC Ͻ 0.70, recruited by medical referral for exercise training. Exclusion criteria were inability to attend a program 3 times/week; metastatic neoplasia; infectious or unstable cardiac diseases; and neuromusculoskeletal, psychiatric, or cognitive disorders. The trial was conducted between January 2009 and March 2010 at the Hospital Pulido Valente in Lisbon, Portugal, with an experienced pulmonary rehabilitation program, which serves 350,000 inhabitants. The hospital's ethics committee and administrative board approved the trial conduction (institutional review board DIRCLIN-07.ABR.2009-0256), and all subjects gave written informed consent. The trial is registered as NCT01944072.
The intervention consisted of a 20-session out-patient pulmonary rehabilitation program of therapeutic exercise (aerobic, strength, and flexibility) plus education and skills training. Aerobic exercise was 30 min of training 3 times/ week on a treadmill (Light Commercial Europe, Mercury BH, Vitoria-Gasteiz, Spain) or bicycle (Erg602BE, Dimeq, Berlin, Germany) according to subjects' preference, with an intensity of 60% W max (group 1) or 80% W max (group 2) of an initial incremental exercise test. 3 Strength training was combined 2 times/week with multi-station equipment (CybexMG500 Multi-Gym, Cybex, Medway, MA) in 3 sets of 8 repetitions at 50% of one-repetition maximum for selected exercises (seated leg press, seated calf raise, seated row, abdominal crunch, and chest press). Flexibility training was combined 3 times/week with 5 s of stretching for each of 7 selected large body muscle exercises. There were 5 education and skills training group-oriented sessions: COPD, medication and respiratory devices, breathing exercises, bronchial hygiene techniques, and benefits of physical exercise. HRQOL was the primary outcome measured by the St George Respiratory Questionnaire (SGRQ), 20 with a score ranging from 0 to 100, with higher scores meaning worse HRQOL. Secondary outcomes were symptom control measured by Mahler's dyspnea index 21 (scores ranging from Ϫ9 to ϩ9, with positive scores meaning improvement in dyspnea) and by the London Chest Activity of Daily Living (LCADL) scale 22 (scores ranging from 0 to 75, with higher scores meaning more limitations on activities of daily living) and exercise tolerance assessed by a 6-min walk test (6MWT) 23 (functional capacity), incremental exercise test 3 (peak aerobic capacity), and constant-load exercise test 3 (endurance capacity). The minimum clinically important differences were: Ϯ4 for the SGRQ, 24,25 1 point for the transitional dyspnea index, 24 -26 25 m for the 6-min walk distance (6MWD), 27 
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Current knowledge
COPD is the world's fourth leading cause of mortality and is projected to be the fifth leading disease in morbidity impact by 2020. Exercise intolerance in these patients is associated with both worsening morbidity and mortality. Pulmonary rehabilitation including exercise training has met with mixed results in improving quality of life and symptoms. The optimum intensity of exercise during rehabilitation is frequently debated.
What this paper contributes to our knowledge
During pulmonary rehabilitation, aerobic training intensity of at least 60% maximum work rate (W max ) had a positive impact in COPD subject-centered outcomes, with no additional benefit of increasing intensity to 80% W max in health-related quality of life, symptom control, and exercise tolerance. Work intensity needs to be sufficient to provide benefit without resulting in exercise intolerance.
and 100 s for the constant-load exercise test. 28, 29 The incremental exercise and constant-load exercise tests were assessed before and after the pulmonary rehabilitation program; all other outcomes were also accessed at the tenth session for intention-to-treat analysis. Considering the primary outcome, 34 subjects were studied for a clinically important target difference of 12 points in the SGRQ 24, 25 between intervention groups (group 1, n ϭ 17; group 2, n ϭ 17). This sample size was statistically calculated using the PS: Power and Sample Size Calculation program (Vanderbilt University, Nashville, Tennessee), with 5% significance level, a power of 80%, an SGRQ SD of 11.33 points, 30 and a 10% predicted dropout rate. A subject's allocation sequence was computer-generated, and the randomization was stratified by a cutoff value of 0.50 FEV 1 , with an allocation ratio of 1:1 using random block sizes of 2 (mild to moderate COPD, severe to very severe COPD). The research physiotherapist assessed eligibility, discussed the trial, and obtained informed consent from the subject. Another physiotherapist adapted the subject to the treadmill or bicycle, and only after the chest physician assessed the subject by an incremental exercise test was an allocation consignment given according to a schedule maintained in a safe deposit box. This was a subject-blinded study, as all subjects participated in the same pulmonary rehabilitation program with individualized aerobic intensity training from the incremental exercise test but could not differentiate who was training at 60 or 80% W max . Blinding was not applied to health-care providers due to their role in monitoring intensity targets of aerobic training. Statistical analysis was conducted with PASW Statistics 18.0.0 (SPSS, Chicago, Illinois), with a modified intention-totreat analysis considering a minimum of 10 sessions of attendance of the pulmonary rehabilitation program. Primary outcome was change in the SGRQ, with the total and impact scores analyzed with the Satterthwaite test (normal distribution and unequal variances) and activity and symptom scores analyzed with the Student t test (normal distribution and equal variances). Secondary outcomes were change in the transitional dyspnea index, LCADL scale, incremental exercise test, and constant-load exercise test (analyzed by the Mann-Whitney U test, non-normal distribution) and change in 6MWD (analyzed by the Student t test, normal distribution and equal variances). All outcomes were also analyzed for inferential statistics with the Pearson coefficient (continuous variable) except for the transitional dyspnea index and LCADL scale, which were analyzed with the Spearman coefficient (ordinal variable).
Results
As shown in Figure 1 , a total of 56 subjects were recruited between January and December of 2009, with 22 excluded, and the trial was stopped when the sample size goal was achieved (n ϭ 34). The intervention phase was February 2009 to March 2010. Table 1 presents subjects' baseline demographic and clinical characteristics. The 20-session pulmonary rehabilitation program had a mean duration of 8.2 Ϯ 1.8 weeks for group 1 and 7.9 Ϯ 2.9 weeks for group 2.
For the purpose of analysis, treadmill and bicycle intensity units were converted to metabolic equivalents by American College of Sports Medicine formulas. 31 The mean intensity of the aerobic exercise training was 4.3 Ϯ 0.9 metabolic equivalents for group 1 and 5.5 Ϯ 1.8 metabolic equivalents for group 2, which correspond to an overall mean efficiency of aerobic training intensity exercised/ prescribed of 87.1% (group 1 ϭ 92%, group 2 ϭ 82%). Determined by the subjects' choice, both groups were similar, considering the training modality (76% treadmill and 24% bicycle) and the type of training (94% continuous and 6% interval). All subjects had 100% efficiency of strength training intensity exercised/prescribed (ie, 50% of onerepetition maximum) and attended the education and skills training group sessions as programmed.
The primary analysis was modified intention to treat with 31 of 34 subjects randomly assigned (see Fig. 1 ) due to follow-up loss of 3 subjects before the tenth session of the pulmonary rehabilitation program (respiratory infection, professional reasons, and lower-limb pain). Secondary analysis of Mahler's dyspnea index, LCADL scale, and 6MWT was carried out on 30 subjects because of the loss to follow-up of one subject (thyroid dysfunction with atrial fibrillation) at the thirteenth session of the pulmonary rehabilitation program without completing the overall assessment; the constant-load exercise and incremental exercise tests were analyzed for 28 subjects since there were 
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As shown in Table 2 , there was significant improvement in all outcomes, as all results exceeded the known minimum clinically important difference in both groups. Each group exceeded a 3-fold minimum clinically important difference of 1 point in the transitional dyspnea index 24 -26 (almost a 4-fold minimum clinically important difference of 25 m in the 6MWD) 27 and improved by Ͼ 100 s the minimum clinically important difference in the constantload exercise test, 28, 29 and both groups presented an improvement in the LCADL scale and incremental exercise test but without any clinical conclusion regarding its unknown minimum clinically important difference.
In primary analysis, the difference in mean changes in HRQOL between groups was not statistically significant. Although each group differed by Ͼ 4 points in the minimum clinically important difference 24, 25 in all SGRQ scores, between groups, the results fell short of the 12-point effect size predefined in the trial design. In secondary analysis, the difference between groups in mean changes as an effect of aerobic training intensity of 60 or 80% W max in HRQOL, symptom control, and exercise tolerance was also not statistically significant.
As expected by the ancillary analysis, age was inversely correlated with the 6MWD (initial 6MWD, ϭ Ϫ0.45, P ϭ .01; final 6MWD, ϭ Ϫ0.53, P Ͻ .001) and with duration of the constant-load exercise test (initial constantload exercise test, ϭ Ϫ0.48, P ϭ .01; final constant-load exercise test, ϭ Ϫ0.62, P Ͻ .001). Nevertheless, there was no statistical correlation between age and improvements in the 6MWD ( ϭ 0.07, P ϭ .71) and constant-load exercise test ( ϭ Ϫ0.27, P ϭ .16).
There were 5 adverse events during the trial, only one exercise-related, during the eleventh session of the pulmonary rehabilitation program with tachycardia, arrhythmia, and angina in a subject with heart disease history (group 1). After acute heart ischemia was excluded in the emergency room, the subject returned to the pulmonary rehabilitation program, which concluded without any other adverse events. Other adverse events not exercise-related were lower-limb pain related to lumbar hernia in one subject (group 2); gastrointestinal symptoms in 2 subjects (group 2), with one being surgically treated; thyroid dysfunction with atrial fibrillation in one subject (group 2); and respiratory infection in another one (group 1).
Discussion
In the literature, aerobic training protocols present a wide variety of types, modalities, durations, frequencies, and intensities, making a rigorous comparison of published findings difficult. This study outlined the equivalence effect of 2 aerobic training intensities on patient-centered outcomes. The main conclusion is that there were significant improvements in all outcomes for both intensities (60 and 80% W max ), but there were no differences between groups in mean changes in HRQOL, symptom control, and exercise tolerance.
Effect of Aerobic Training Intensity on HRQOL
The methodology of the pulmonary rehabilitation program with the SGRQ as an outcome is hugely diverse in the published studies, as shown by the meta-analysis of Lacasse et al 32 and the systematic review of Puhan et al. 33 
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These publications did not address the isolated effect of aerobic training intensity on patient-centered outcomes, and the evidence presented favoring high versus low intensity was weak. There is evidence of a positive effect on HRQOL, as shown by studies by Bernard et al, 34 Pereira et al, 35 Montes de Oca et al, 36 Dourado et al, 37 Arnardóttir et al, 38 and Foglio et al, 39 , even considering the wide range of intensities in those heterogeneous pulmonary rehabilitation program interventions (type, modality, duration, and frequency). The multi-center study by Laviolette et al 28 with 168 subjects with COPD also found improvement in the SGRQ after the pulmonary rehabilitation program but lacked any description of the exercise intensity applied. As far as we know, only the Normandin study 40 with 40 subjects with COPD in an 8-week pulmonary rehabilitation program compared high (at least 80% W max ) with moderate intensity (calisthenics class). They found no differences between groups in HRQOL assessed by the chronic respiratory questionnaire. Our study also outlines the equivalence impact of moderate and high aerobic intensities on HRQOL but further refines moderate intensity as 60% W max and high intensity as 80% W max in a comparable exercise prescription.
Effect of Aerobic Training Intensity on Symptom Control
The results of this study show that aerobic intensity of at least 60% W max has a positive impact on symptom control assessed by the transitional dyspnea index, without any superior effect of higher intensities. These findings are in accordance with the above-mentioned studies by Dourado et al, 37 Foglio et al, 39 and Normandin et al 40 with no differences between groups.
Effect of Aerobic Training Intensity on Exercise Tolerance
International guidelines present evidence of physiological benefits associated with higher aerobic training intensities, 41 in accordance with historical studies by Casaburi et al, 42 Maltais et al, 43 Puente-Maestu et al, 44 and Gimenez et al, 45 but also more recently by Lacasse et al, 32 Laviolette et al, 28 Bernard et al, 34 Montes de Oca et al, 36 Dourado et al, 37 Arnardóttir et al, 38 Foglio et al, 39 Normandin et al, 40 and Hsieh et al. 46 Those studies reported improvements in the 6MWT, incremental exercise test, and constant-load exercise test with a pulmonary rehabilitation program but without any evidence of significant differences in these outcomes as an effect of the aerobic training intensities applied. On the other hand, more research is needed focusing on patients' goals. 47 The results of our study demonstrate that there is no superior effect of higher intensities in aerobic training on patient-centered outcomes. Therefore, different physiological effects as a result of different training intensities might have a similar impact on patients with COPD.
Overall, there were no differences between groups in mean changes in HRQOL, symptom control, and exercise tolerance as a result of aerobic training at 60 or 80% W max . 
Age Correlation With the 6MWT and Constant-Load Exercise Test
According to our study, the older subjects walked shorter distances in the 6MWT and achieved shorter durations in the constant-load exercise test, both at baseline and during final assessments, but interestingly, there was no relation between age and improvement in these exercise-related outcomes. This indicates that age cannot be a predictive factor for the level of benefit from a pulmonary rehabilitation program, and this fact must be taken into account when enrolling elderly subjects.
Limitations
Among the 34 subjects studied, there were 6 adverse events, only one of them exercise-related, which did not become a loss to follow-up. Internal study validity was preserved with 31 subjects studied (group 1, n ϭ 15; group 2, n ϭ 16), in accordance with a sample size calculation of 15 subjects/group. Double or triple blinding was not applied, considering the tight exercise monitoring by physiotherapists.
The aerobic training intensity attained versus prescribed was 92% in group 1 and 82% in group 2. The reason for this might have been the strict length of the 8-week program as defined by the protocol. Moreover, clinical practice shows that many subjects attain the target intensity with longer programs. Although it was not the purpose of our study, future research should focus on the impact of different training intensities on physical activity of daily life as a meaningful patient-centered outcome.
Conclusions
Health-care providers acknowledge the level A recommendation of a pulmonary rehabilitation program with therapeutic exercise for all symptomatic patients with COPD. This study evidenced an equivalence effect of moderate and high intensities on HRQOL, symptom control, and exercise tolerance. The implication for clinical practice is that aerobic training intensity should be at least 60% W max to achieve not only physiological benefits but also patientcentered outcomes, challenging the present clinical attitude of rehabilitation professionals. Continuing the present study, future research should address the impact of designing specific training activities related to the patient's real living environment and also the long-term effects on physical activity in daily life.
